AAPS Open | |
PEGylated magnetic nanographene oxide for targeted delivery of arsenic trioxide and sec-o-glucosylhamaudol in tumor treatment with improved dual-drugs synergistic effect | |
Research | |
Miyi Yang1  Yu Zhao1  Jianhui Sun1  Qinghe Zhao1  Hongmei Li1  Kun Hong1  Yuqing Tan1  Jinlai Cheng1  | |
[1] China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica, Dongzhimen Nei Ave. Nanxiaojie 16#, Dongcheng District, 100700, Beijing, China; | |
关键词: Synergistic effect; Arsenic trioxide; Sec-o-Glucosylhamaudol; Magnetic graphene oxide; Drug-delivery; | |
DOI : 10.1186/s41120-023-00079-4 | |
received in 2022-12-15, accepted in 2023-05-08, 发布年份 2023 | |
来源: Springer | |
【 摘 要 】
Arsenic trioxide (ATO) is a promising chemotherapeutic agent, but its clinical application is limited due to its poor pharmacokinetics and dose-limited toxicity. Moreover, the combination of ATO and sec-o-glucosylhamaudol (SOG) can improve the therapeutic effect of hepatoma. In this study, PEGylated magnetic nanographene oxide (PEG@MGO) was used as magnetic carriers to enhance the targeting ability of the drug delivery system. ATO and SOG are loaded on the surface of PEG@MGO nanoparticles through electrostatic interactions. This biocompatible nanocomposite shows magnetic susceptibility, pH sensitivity, and high loading capacity of the drugs. The in vitro cytotoxicity study of human hepatoma cell line (HepG2) cells showed more significant cytotoxicity and obvious synergistic effect between ATO and SOG compared with that of single drug-loaded nanoparticles via MTT assay. In vitro cellular uptake was observed by Prussian blue staining and fluorescently labeling. The results demonstrated a high cellular internalization rate of PEG@MGO. The ATO and SOG co-loaded nanodrug significantly inhibits the growth of tumors in vivo, which might be due to the oxidative stress and proapoptotic effect. This type of multidrug nanocomposite offers a promising alternative for cancer therapy.Graphical AbstractA pH-sensitive polyethylene glycol-modified magnetic graphene oxide loaded with ATO and SOG (PEG@MGO@ATO + SOG) was prepared for the magnetically targeted and efficient synergistic-chemo cancer therapy, which exhibited high specificity and good biocompatibility.
【 授权许可】
CC BY
© The Author(s) 2023
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202309077785997ZK.pdf | 6573KB | download | |
40517_2023_252_Article_IEq86.gif | 1KB | Image | download |
40517_2023_252_Article_IEq95.gif | 1KB | Image | download |
Fig. 1 | 147KB | Image | download |
Fig. 2 | 290KB | Image | download |
Fig. 3 | 353KB | Image | download |
40517_2023_252_Article_IEq125.gif | 1KB | Image | download |
MediaObjects/13690_2023_1111_MOESM1_ESM.docx | 59KB | Other | download |
Fig. 6 | 304KB | Image | download |
40517_2023_252_Article_IEq132.gif | 1KB | Image | download |
【 图 表 】
40517_2023_252_Article_IEq132.gif
Fig. 6
40517_2023_252_Article_IEq125.gif
Fig. 3
Fig. 2
Fig. 1
40517_2023_252_Article_IEq95.gif
40517_2023_252_Article_IEq86.gif
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]